Investment Information

With transparent disclosure of information and communication with markets,
we will grow along with shareholders.

Corporate Governance Structure

Company Overview

(As of March 30, 2023)
Company Overview
Type Announcement
Representative Sean (Seungwon) Jeong, Su-jin Park
Established on November 20, 1973
Listed on December 18th 1989 (listed on KOSPI)
Largest Shareholder Daewoong Pharmaceutical Co., Ltd.
Capital 26.1 billion KRW
Nominal Value 500 KRW
Total Issued shares 52,240,638
Number of Employees 314 (As of Dec.31, 2022)
Board of Directors
Name Background
Sean (Seungwon) Jeong, M.d., MBA President & Chief Executive Officer; Former Head of Bone Japan/China, UCB; Former New Products Director, Novartis
Su-jin Park Vice President & Chief Executive Officer; Former Head of ETC Sales Division, Daewoong Pharmaceutical
Jae-chun Yoon Chairman, Board of Directors; Chief Executive Officer, Daewoong Pharmaceutical
Seung-kook Park, Ph.D. Former President & Chief Executive Officer; Former Head of R&D, Daewoong Pharmaceutical
Cheol-hun Lee Independent Director; Chief Executive Officer, Lee Cheol-hun Accounting Firm Partner
Han-joo Kim, Ph.D. Independent Director; Founder & Chief Executive Officer, IMNEWRUN
Hun Jung, M.D., Ph.D. Independent Director; Founder & Chief Executive Officer, Aston Science